PA
ZBRA icon

PharVision Advisers’s Zebra Technologies ZBRA Stock Holding History

PharVision Advisers’s Portfolio ZBRA Stock Details ZBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-727
Closed -$216K – 1044
2025
Q3 		$216K Buy
+727
New +$232K 0.12% 450
2025
Q2 		– Sell
-1,338
Closed -$378K – 451
2025
Q1 		$378K Buy
+1,338
New +$457K 0.52% 46

Other funds holding ZBRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PharVision Advisers's ZBRA Position: Q4 2025 in Review

PharVision Advisers sold out of Zebra Technologies (ZBRA) in Q4 2025, closing a stake of 727 shares — an estimated $216K sold.

PharVision Advisers first reported a position in ZBRA in Q1 2025 and held it in 2 quarters. The position peaked at $378K in Q1 2025. 708 funds tracked by Wall St. Rank hold ZBRA as of Q4 2025.

  • PharVision Advisers reported no remaining Zebra Technologies position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 727 Zebra Technologies shares in Q4 2025, an estimated $216K.
  • PharVision Advisers first reported a position in Zebra Technologies in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Zebra Technologies position peaked at $378K in Q1 2025.
  • 708 funds tracked by Wall St. Rank held Zebra Technologies as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.